alexa Tacrolimus Significantly Improves Symptoms In Children With Myasthenia Gravis Refractory To Prednisone
ISSN: 2165-7939

Journal of Spine
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

CO-ORGANIZED EVENT:2nd International Conference on Spine and Spinal Disorders & 6th International Conference on Neurology and Neuromuscular Diseases
July 24-26, 2017 Rome, Italy

Mengcui Gui, Yayun Cao, Jing Lin, Yue Li, Suqiong Ji, Bitao Bu and Chanchan Liu
Huazhong University of Science and Technology, China
Posters & Accepted Abstracts: J Spine
DOI: 10.4172/2165-7939-C1-006
Abstract
Myasthenia gravis is a common autoimmune neurologic disease in China. More than half of myasthenia gravis cases are children (or juvenile) who predominantly manifested isolated ocular weakness. However, pyridostigmine and oral prednisone could improve the symptoms to some degree; the children will display multiple side effects such as Cushing reaction and retarded stature. In attempt to overcome the flaws of prednisone therapy and to obtain more stabilized improvement of myasthenia gravis symptoms, we aimed to test the efficacy and safety of tacrolimus, a novel immunosuppressant, in a cohort of myasthenia gravis children. Fourteen children with myasthenia gravis (aged more than 5 and 14 years) who had not achieved satisfactory improvement or/and suffered from severe side effects of oral prednisone were recruited between January 2014 and May 2015 at Tongji Hospital. Only one child withdrew from the study because he complained of slight dizziness and nausea, and the remaining 13 children completed the therapy for 1 year. After the treatment with tacrolimus (1-2 mg per day), doses of prednisone were significantly decreased, the myasthenia gravis symptoms, evaluated by quantitative myasthenia gravis score, myasthenia gravis-specific manual muscle testing and myasthenia gravis-activities of daily living score in the children were significantly improved at weeks 12 and thereafter. In addition, 10 (76.9%) patients had completely stopped using prednisone, accordingly, the major side effects were reversed. The titer of acetylcholine autoantibodies significantly dropped from 1.96±2.62 nmol/L to 0.70±1.04 nmol/L (P<0.05). During the follow-up, no severe adverse events were reported. Our result provided a novel therapy for children with myasthenia gravis who did not respond well to oral prednisone or/and had major side effects of oral prednisone. Tacrolimus is safe in children and is able to stabilizing improve the isolated ocular weakness of children with myasthenia gravis.
Biography

Mengcui Gui has her expertise in Neuroimmunology. She along with her team has already established clinical data and biological information collecting system on myasthenia gravis, multiple sclerosis, myolitis, etc. Also, she has built the animal model after years of experience in research, evaluation and administration both in hospital and education institutions.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords